Aspira Women's Health to restate financial reports over cash flow classification errors
AWHL•
AWHL•Aspira Women's Health will restate its financial statements for the three months ended March 31 and six months ended June 30, 2026, after identifying material cash-flow classification errors. The errors did not affect total cash changes, but management identified a material weakness in financial reporting controls and disclosure procedures.
Aspira Women's Health said it will restate financial statements for the three months ended March 31 and six months ended June 30, 2026. On November 13, the audit committee determined that the statements should no longer be relied upon because loan proceeds and related payments were misclassified as operating rather than financing activities; total cash changes were unaffected.
Management concluded that financial reporting controls and disclosure procedures were ineffective for both periods and identified a material weakness.